Author(s): Shao CJ, Kasai R, Ohtani K, Xu JD, Tanaka O
Hederagenin, delta-hederin [hederagenin alpha-L-arabinoside], kalopanax-saponin A [hederagenin 3-O-alpha-L-rhamnosyl(1-->2)-alpha-L- arabinoside], kalopanaxsaponin I [hederagenin 3-O-beta-D-xylosyl(1-->3)-alpha-L- rhamnosyl(1-->2)-alpha-L-arabinoside], and sapindoside C [hederagenin 3-O-beta-D-glucosyl(1-->4)-beta-D-xylsyl (1-->3)-alpha-L-rhamnosyl(1-->2)-alpha-L-arabinoside] were isolated from stem bark of Kalopanax pictus Nakai (Araliaceae). Among glycosides of hederagenin, disaccharide (kalopanaxsaponin A, commonly also called alpha-hederin), trisaccharide (kalopanaxsaponin I), and tetrasaccharide (sapindoside C) showed significant cytotoxicity on several types of tumor cells, while hederagenin itself exhibited only weak cytotoxicity and its monosaccharide (delta-hederin) was non-cytotoxic. From these results, it suggests that the arabinosyl moiety at C-3 blocks the activity of hederagenin and the position of the second sugar for glycoside linkage is also important for cytotoxicity. In the in vivo experiments, kalopanaxsaponin A (15 mg/kg, i.p.) apparently increased the life span of mice bearing Colon 26 and 3LL Lewis lung carcinoma, as well as cisplatin (3 mg/kg, i.p.). These results indicated that kalopanaxsaponin A has potential anti-tumor applications.
Referred From: https://pubmed.ncbi.nlm.nih.gov/11301855/
Author(s): Liu CX, Xiao PG
Author(s): Xie JT, Aung HH, Wu JA, Attele AS, Yuan CS
Author(s): Attele AS, Wu JA, Yuan CS
Author(s): Kitagawa I, Taniyama T, Shibuya H, Noda T, Yoshikawa M
Author(s): Chan TWD, But PPH, Cheng SW, Kwok IMY, Lau FW, et al.
Author(s): Yamaguchi H, Kasai R, Matsuura H, Tanaka O, Fuwa T
Author(s): Wang X, Sakuma T, Asafu-Adjaya E, Shiu GK
Author(s): Tanaka H, Fukuda N, Shoyama Y
Author(s): Fukuda N, Tanaka H, Shoyama Y
Author(s): Morinaga O, Takuhiro U, Yuan CS, Tanaka H, Shoyama Y
Author(s): Fukuda N, Tanaka H, Shoyama Y
Author(s): Tanaka H, Kukuda N, Shoyama Y
Author(s): Tanaka H, Putalun W, Tsuzaki C, Shoyama Y
Author(s): Shan S, Tanaka H, Shoyama Y
Author(s): Tanaka H, Fukuda N, Shoyama Y
Author(s): Lee YN
Author(s): Cai XF, Shen G, Dat NT, Kang OH, Kim JA, et al.
Author(s): Cai XF, Lee IS, Dat NT, Shen G, Kang JS, et al.
Author(s): Choi HS, Kim HJ, Nam SG, Kim IS, Lee KT, et al.
Author(s): Nhiem NX, Tung NH, Kiem PV, Minh CV, Ding Y, et al.
Author(s): Zou K, Zhu S, Meselhy MR, Tohda C, Cai S, et al.
Author(s): Morita T, Tanaka O, Kohda H
Author(s): Tanaka H, Fukuda N, Shoyama Y
Author(s): Yao HK, Duan JY, Li Y, Wang JH, Yin XX, et al.
Author(s): Court WE
Author(s): Jin Y, Hofseth AB, Cui XL, Windust AJ, Poudyal D, et al.
Author(s): Li BH, Wang CZ, He TC, Yuan CS, Du W
Author(s): Yuan CS, Dey L
Author(s): Qi LW, Wang CZ, Yuan CS
Author(s): Yuan CS, Wang CZ, Wicks SM, Qi LW
Author(s): Tung NH, Shoyama Y
Author(s): Putalun W, Tanaka H, Shoyama Y